JUNSHI BIO Sets 26 August 2026 Board Meeting to Review 1H 2026 Results

Bulletin Express08-12

Shanghai Junshi Biosciences Co., Ltd. (JUNSHI BIO) has scheduled a board meeting for 26 August 2026 in Shanghai to consider and approve the Group’s interim financial results for the six months ended 30 June 2026. The agenda will also include other corporate matters.

The board currently comprises seven executive directors—Xiong Jun (Chairman), Li Ning, Zou Jianjun, Li Cong, Zhang Zhuobing, Wang Gang and Li Xin—alongside two non-executive directors, Yao Sheng and Tang Yi, and five independent non-executive directors, Feng Xiaoyuan, Li Zhongxian, Lu Kun, Yang Jin and Chen Liang.

Further details, including financial figures for the first half of 2026, are expected to be released following board approval.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment